Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00593307 · ClinicalTrials.gov registry record · NA

The Breakfast Study

A NA study of Hunger and Glycemic Response, sponsored by Temple University.

Completed
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT00593307 is a NA study of Hunger and Glycemic Response that has completed, run by Temple University. The registered enrollment target is 24 participants, below the 83-participant average among 7 other Hunger trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00593307, a NA study of Hunger and Glycemic Response, has completed, sponsored by Temple University.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

The overall objective is to investigate the effects of low and high glycemic index (GI) meals varying in protein content on plasma glucose and insulin response, subjective ratings of hunger, and subsequent food intake in twenty healthy, sedentary, overweight and obese men and women between the ages of 21-65.

Conditions Studied

Interventions

  • OTHER high GI
  • OTHER Low GI
  • OTHER Low GI Low Carb
  • OTHER High GI Low carb

Study Locations (1)

Pennsylvania

  • Temple University - Center for Obesity Research and Education - Philadelphia

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2006-01
Est. Completion 2008-06
Phase NA

Sponsor

Temple University

163 total trials

What the Registry Record Tells You About NCT00593307

The ClinicalTrials.gov registry entry for NCT00593307 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 83-participant average among 7 other Hunger trials with a reported enrollment target (71% lower). The listed sponsor is Temple University, which has 163 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Hunger appearing as the primary indexed condition, and to 4 interventions - of which high GI is the first listed.

NCT00593307 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00593307 about?

NCT00593307 is a clinical study titled "The Breakfast Study". The overall objective is to investigate the effects of low and high glycemic index (GI) meals varying in protein content on plasma glucose and insulin response, subjective ratings of hunger, and subsequent food intake in twenty healthy, sedentary, overweight and obese men and women between the ages ...

What is the current status of trial NCT00593307?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2006-01. Estimated completion is 2008-06.

What conditions does trial NCT00593307 study?

This clinical trial studies the following conditions: Hunger, Glycemic Response.

What interventions are being tested in trial NCT00593307?

The interventions under investigation include: high GI (OTHER), Low GI (OTHER), Low GI Low Carb (OTHER), High GI Low carb (OTHER).

Who is sponsoring clinical trial NCT00593307?

This trial is sponsored by Temple University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00593307 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hunger

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.